Lilian Lil Bianchi

Ms Bianchi is a Chair and NED, guiding medtech companies through growth inflection points and international expansion, including 4DMedical (ASX:4DX) and Qscan Radiology Group. Ms Bianchi brings a track record of guiding medical technology companies as they navigate growth inflection points and accelerate global market adoption including the US and Europe. With experience spanning business transformation, AI and SaaS technologies, governance and capital markets, she has helped lead companies through expansion, commercialisation and international growth. Her experience across global corporates, tech start-ups and IPO environments positions her to guide companies in scaling innovative medical technologies into healthcare markets. Combining board, CEO and senior executive leadership experience with a background in strategy, risk and digital disruption, Ms Bianchi has ability to help companies convert breakthrough technology into commercial traction and long-term shareholder value. Ms Bianchi is Chair of medtech company 4DMedical (ASX:4DX), a global leader in respiratory imaging that has grown from IPO in 2020 to a $2b plus market capitalisation and entry to the ASX200 in 2026.